NextPlat Corp (NXPL)

Lumos Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.74	19.96	26.31	18.89	17.27	0.73
Cash & Short-Term Investments	17.74	19.96	26.31	18.89	17.27	0.73
Cash Growth	-24.61%	-24.13%	39.26%	9.40%	2269.49%	867.01%
Accounts Receivable	5.8	5.13	9.11	0.53	0.45	0.25
Other Receivables	2.03	1.1	2.19	0.43	0.49	-
Receivables	7.83	6.24	11.56	0.96	0.94	0.25
Inventory	4.51	4.88	5.14	1.29	1.02	0.36
Prepaid Expenses	0.4	0.4	0.64	0.05	0.1	0
Other Current Assets	-	-	-	-	0.05	0.03
Total Current Assets	30.48	31.48	43.64	21.18	19.37	1.37
Property, Plant & Equipment	3.98	4.22	5.58	2.1	1.07	1.16
Long-Term Investments	-	-	-	5.26	-	-
Goodwill	0.16	0.16	0.73	-	-	-
Other Intangible Assets	0.5	0.52	14.42	0.05	0.08	0.1
Other Long-Term Assets	0.09	0.09	0.1	0.05	0.05	-
Total Assets	35.2	36.48	64.47	28.64	20.57	2.63
Accounts Payable	6.75	6.6	12.14	1.2	0.85	0.75
Accrued Expenses	0.68	0.54	0.96	0.15	0.07	0.15
Short-Term Debt	0.03	0.05	0.02	0.03	0.04	0.1
Current Portion of Long-Term Debt	0.31	0.38	0.31	0.06	0.06	0.16
Current Portion of Leases	0.39	0.41	0.55	0.21	0.02	0.03
Current Income Taxes Payable	0.07	0.05	0.14	0.09	0.06	0.02
Current Unearned Revenue	0.14	0.09	0.04	0.04	0.04	0.04
Other Current Liabilities	0.07	0.1	0.08	0.29	1.66	0.27
Total Current Liabilities	8.42	8.21	14.24	2.06	2.78	1.52
Long-Term Debt	0.98	1.03	1.21	0.16	0.25	0.53
Long-Term Leases	0.35	0.44	0.93	0.65	-	0.02
Total Liabilities	9.75	9.68	16.38	2.87	3.03	2.07
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	75.7	75.7	67.17	56.96	39.51	14.49
Retained Earnings	-50.29	-48.95	-34.93	-31.15	-21.99	-13.88
Comprehensive Income & Other	-0.08	-0.07	-0.06	-0.04	0	-0.04
Total Common Equity	25.34	26.68	32.18	25.78	17.53	0.57
Minority Interest	0.11	0.11	15.9	-	-	-
Shareholders' Equity	25.45	26.8	48.09	25.78	17.53	0.57
Total Liabilities & Equity	35.2	36.48	64.47	28.64	20.57	2.63
Total Debt	2.05	2.31	3.03	1.1	0.37	0.85
Net Cash (Debt)	15.68	17.65	23.28	17.79	16.9	-0.12
Net Cash Growth	-24.16%	-24.18%	30.89%	5.24%	-	-
Net Cash Per Share	0.70	0.86	1.33	1.85	4.14	-5.63
Filing Date Shares Outstanding	25.96	25.96	18.72	14.44	9.29	1.24
Total Common Shares Outstanding	25.96	25.96	18.72	14.4	7.05	0.82
Working Capital	22.05	23.27	29.4	19.12	16.59	-0.14
Book Value Per Share	0.98	1.03	1.72	1.79	2.49	0.69
Tangible Book Value	24.68	26	17.03	25.73	17.46	0.47
Tangible Book Value Per Share	0.95	1.00	0.91	1.79	2.47	0.57
Land	0.18	0.18	0.18	-	-	-
Buildings	2.12	2.12	2.12	-	-	-
Machinery	1.44	1.42	1.3	0.24	0.14	0.09
Construction In Progress	-	-	0.02	-	-	-
Leasehold Improvements	0.18	0.18	0.12	0.05	-	-

Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q